SCHEMBL21895745

SCHEMBL21895745

C=CCCCc1c(CC)nc(OCCCN2C[C@H]3C[C@@H]2CO3)nc1N(CCC(C=C)C(=O)C=C)CC(C)CC#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19637857 0.89 — —
SCHEMBL21846436 0.79 KRAS (0.35) —
SCHEMBL21895589 0.73 — —
SCHEMBL21895536 0.72 TLR7 (0.38) —
SCHEMBL19637855 0.72 — —
SCHEMBL21912368 0.69 — —
SCHEMBL21846355 0.64 — —
SCHEMBL21895575 0.63 — —
SCHEMBL25020009 0.62 — —
SCHEMBL21846218 0.61 HRH3 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020055756-A1 COMBINATION THERAPIES Mirati Therapeutics, Inc. (US) 2020-03-19 — — WO disclosed
Send feedback